Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4781666
Max Phase: Preclinical
Molecular Formula: C39H55N5O10
Molecular Weight: 753.89
Molecule Type: Unknown
Associated Items:
ID: ALA4781666
Max Phase: Preclinical
Molecular Formula: C39H55N5O10
Molecular Weight: 753.89
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@H](CCC(=O)OCCOCCN=[N+]=[N-])[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](OC(=O)[C@H](CC(=O)O)NC(=O)c5ccc([N+](=O)[O-])cc5)CC[C@]4(C)[C@H]3CC[C@]12C
Standard InChI: InChI=1S/C39H55N5O10/c1-24(4-13-35(47)53-21-20-52-19-18-41-43-40)30-11-12-31-29-10-7-26-22-28(14-16-38(26,2)32(29)15-17-39(30,31)3)54-37(49)33(23-34(45)46)42-36(48)25-5-8-27(9-6-25)44(50)51/h5-6,8-9,24,26,28-33H,4,7,10-23H2,1-3H3,(H,42,48)(H,45,46)/t24-,26-,28-,29+,30-,31+,32+,33+,38+,39-/m1/s1
Standard InChI Key: GZRRTSBHFRYQDA-BIAISYAISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 753.89 | Molecular Weight (Monoisotopic): 753.3949 | AlogP: 7.03 | #Rotatable Bonds: 17 |
Polar Surface Area: 220.13 | Molecular Species: ACID | HBA: 10 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.55 | CX Basic pKa: | CX LogP: 6.31 | CX LogD: 2.83 |
Aromatic Rings: 1 | Heavy Atoms: 54 | QED Weighted: 0.03 | Np Likeness Score: 0.78 |
1. Fu CW,Tsai HE,Chen WS,Chang TT,Chen CL,Hsiao PW,Li WS. (2021) Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis., 64 (1.0): [PMID:33371679] [10.1021/acs.jmedchem.0c01477] |
Source(1):